MARKET

WST

WST

West Pharm Svc
NYSE

Real-time Quotes | Nasdaq Last Sale

457.11
+1.89
+0.42%
After Hours: 457.11 0 0.00% 17:29 09/24 EDT
OPEN
454.68
PREV CLOSE
455.22
HIGH
458.59
LOW
451.68
VOLUME
252.63K
TURNOVER
--
52 WEEK HIGH
475.35
52 WEEK LOW
253.86
MARKET CAP
33.82B
P/E (TTM)
66.80
1D
5D
1M
3M
1Y
5Y
Here's Why You Should Retain Masimo (MASI) Stock For Now
Zacks.com · 2d ago
Cutera, NetEase, West Pharmaceutical, IDEXX Laboratories and Align Tech highlighted as Zacks Bull and Bear of the Day
Zacks.com · 3d ago
3 Best ESG Stocks for Those Committed to Sustainable Investing
Investor Place · 3d ago
Buy These 5 Dividend Aristocrats to Strengthen Your Retirement Portfolio
StockNews.com · 4d ago
Bet on These 3 MedTech Growth Stocks for 2021 & Beyond
Zacks.com · 4d ago
Here's Why You Should Retain Inogen (INGN) Stock For Now
Zacks.com · 5d ago
3 Dental Stocks Poised to Perform Well in Second-Half 2021
Zacks.com · 09/16 13:09
Top Ranked Momentum Stocks to Buy for September 15th
CACC, UFPT, WST, and CASH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 15, 2021.
Zacks · 09/15 14:27
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of WST. Analyze the recent business situations of West Pharm Svc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average WST stock price target is 436.00 with a high estimate of 515.00 and a low estimate of 375.00.
EPS
Institutional Holdings
Institutions: 781
Institutional Holdings: 76.09M
% Owned: 102.85%
Shares Outstanding: 73.98M
TypeInstitutionsShares
Increased
217
3.25M
New
99
659.07K
Decreased
209
2.95M
Sold Out
50
171.64K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Non-Executive Chairman/Independent Director
Patrick Zenner
President/Chief Executive Officer/Director
Eric Green
Chief Financial Officer/Senior Vice President
Bernard Birkett
Chief Operating Officer/Senior Vice President
David Montecalvo
Chief Human Resource Officer/Senior Vice President
Annette Favorite
Senior Vice President/Chief Technology Officer
Silji Abraham
Senior Vice President/General Counsel/Secretary
Kimberly Mackay
Chief Accounting Officer/Vice President/Controller
Chad Winters
Vice President/Director of Investor Relations/IR Contact Officer
Quintin Lai
Director
Molly Joseph
Independent Director
Mark Buthman
Independent Director
William Feehery
Independent Director
Robert Friel
Independent Director
Thomas Hofmann
Independent Director
Deborah Keller Tanner
Independent Director
Myla Lai-Goldman
Independent Director
Douglas Michels
Independent Director
Paolo Pucci
Declaration Date
Dividend Per Share
Ex-Div Date
05/05/2021
Dividend USD 0.17
07/20/2021
02/24/2021
Dividend USD 0.17
04/20/2021
12/09/2020
Dividend USD 0.17
01/19/2021
10/28/2020
Dividend USD 0.17
11/09/2020
07/15/2020
Dividend USD 0.16
07/28/2020
02/25/2020
Dividend USD 0.16
04/21/2020
12/13/2019
Dividend USD 0.16
01/21/2020
07/25/2019
Dividend USD 0.16
10/22/2019
05/08/2019
Dividend USD 0.15
07/23/2019
02/21/2019
Dividend USD 0.15
04/16/2019
12/18/2018
Dividend USD 0.15
01/22/2019
05/03/2018
Dividend USD 0.15
10/23/2018
05/03/2018
Dividend USD 0.14
07/17/2018
02/15/2018
Dividend USD 0.14
04/17/2018
12/22/2017
Dividend USD 0.14
01/17/2018
07/20/2017
Dividend USD 0.14
10/17/2017
05/16/2017
Dividend USD 0.13
07/17/2017
02/16/2017
Dividend USD 0.13
04/17/2017
12/14/2016
Dividend USD 0.13
01/13/2017
09/12/2016
Dividend USD 0.13
10/17/2016
About WST
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Webull offers kinds of West Pharmaceutical Services Inc. stock information, including NYSE:WST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WST stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading WST stock methods without spending real money on the virtual paper trading platform.